Research LettersStability and sterility of recombinant tissue plasminogen activator at −30°C
References (3)
- et al.
Coron Thrombolysis Chest
(1998)
There are more references available in the full text version of this article.
Cited by (20)
Thromboembolic complications in children with cancer
2006, Thrombosis ResearchAlteplase and tenecteplase: Applications in the peripheral circulation
2001, Techniques in Vascular and Interventional RadiologyThe use of alteplase to restore patenqy of central venous lines in pediatric patients: A cohort study
2001, Journal of PediatricsCitation Excerpt :In one case series including 5 children, alteplase was successful in 5 of 6 patients at re-establishing patency after UK had failed in all patients.6 The cost effectiveness of alteplase compared with that of other urokinase agents has also been demonstrated.21 The type of CVL did not appear to affect the efficacy or safety of the treatment; however, the distribution of CVL types in our study may not be typical among pediatric centers.
Spectrophotometric analysis of thrombolytic activity: SATA assay
2018, BioImpactsStability of recombinant tissue plasminogen activator at -30 °c over one year
2013, Pharmaceuticals
Copyright © 2000 Elsevier Ltd. All rights reserved.